Netherlands· NL-773d44b56099

Betmiga 50 mg, tabletten met verlengde afgifte

A mirabegron product containing mirabegron, registered in Netherlands by Astellas Pharma Europe B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC G04BD12

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about mirabegronAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Mirabegron is registered in 15 of 19 countries.

Countries holding a registration under ATC G04BD12 (mirabegron), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search mirabegron products by name

Mirabegron · ATC G04BD12

15 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mirabegron costs, country by country.

Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Mirabegron · price per daily dose (50 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.84

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MIRABEGRON
Manufacturer: Astellas Pharma Europe B.V.
Country: Netherlands (NL)
ATC code: G04BD12
ATC class: Mirabegron
Defined daily dose: 50 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/12/809

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

100 interactions on record for mirabegron.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check mirabegron against other medicines How interaction checks work

Mirabegron · interactions on record

100 records

3 severe
26 moderate
71 minor

Most severe, free to view

EliglustatA16AX10severe
VenetoclaxL01XX52severe
TamoxifenL02BA01severe
TrospiumA03AB20moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mirabegron in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mirabegron products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Mirabegron +pharma, Mirabegron G.L.
Belgium · Mirabegron Eg, Mirabegron Teva
Bulgaria · Иретиг, Мирабегрон G.L.
Cyprus · Macitentan, Mirabegron
Czechia · Begirax, Iretig
Germany · Mirabegron Al, Mirabegron Aristo
Denmark · Mirabegron Glenmark, Mirabegron Stada
Estonia · Mirabegron Zentiva, Mirabegron Zentiva K.S.
Spain · Baxirto, Iretig
Finland · Mirabegron Avansor, Mirabegron Glenmark
France · Mirabegron Zentiva, Mirabegron Zentiva L.P.
United Kingdom (Northern Ireland) · Mirabegron Altair, Mirabegron Aspire
Greece · Iretig, Mirabegron Aristo Aristo
Croatia · Iretig, Mezyran
Hungary · Mirabegron Stada
Ireland · Mirabegron Ascend, Mirabegron Clonmel
Iceland · Betmiga, Iretig
Italy · Iretig, Mirabegron Doc
Liechtenstein · Betmiga
Lithuania · Mirabegron Zentiva, Mirabegron Zentiva K.S.
Luxembourg · Mirabegron Eg
Latvia · Mirabegron Zentiva, Mirabegron Zentiva K.S.
Malta · Mirabegron, Mirabegron Clonmel
Norway · Betmiga, Mirabegron Glenmark
Poland · Begirax, Iretig
Portugal · Baxirto, Mirabegrom Alter
Romania · Iretig, Mirabegron G.L. Pharma
Sweden · Mirabegron Avansor, Mirabegron Glenmark
Slovenia · Gozi 25 Mg, Gozi 50 Mg
Slovakia · Mirabegron Glenmark, Mirabegron Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cd739fdb-796a-49db-818a-6d683bdd41c5
GET /v1/drugs/cd739fdb-796a-49db-818a-6d683bdd41c5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/betmiga-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Mirabegron",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp110670",
  "excipients": [
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "MACROGOL 2000000",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)"
  ],
  "substances": [
    "MIRABEGRON"
  ],
  "leaflet_url": null,
  "authorised_at": "2012/12/20",
  "procedure_number": "EMEA/H/C/002388",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/12/809",
  "additional_monitoring": "Y"
}

API reference MCP server Plans

See everything about mirabegron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console